Fol. Biol. 2003, 49, 203-206
https://doi.org/10.14712/fb2003049050203
Immunotherapy of HPV 16-Associated Tumours with Tumour Cell Line/Dendritic Cell Line (TC-1/DC2.4) Hybrid Vaccines
References
1. , J. (2001) Genetically engineered dendritic cellbased cancer vaccines. Int. J. Oncol. 18, 475-478.
2. , C. M., Falo, D. Jr. (1998) Physical interaction between dendritic cells and tumor cells results in an immunogen that induces protective and therapeutic tumor rejection. J. Immunol. 160, 3081-3085.
<https://doi.org/10.4049/jimmunol.160.7.3081>
3. , D., Xia, J., Tanaka, Y., Chen, H., Koido, S., Wernet, O., Mukherjee, P., Gendler, S. J., Kufe, D., Gong, J. (2003) Immunotherapy of spontaneous mammary carcinoma with fusions of dendritic cells and mucin 1-positive carcinoma cells. Immunology 109, 300-307.
<https://doi.org/10.1046/j.1365-2567.2003.01656.x>
4. , B. J., Morton, J. (2003 ) CD1a-positive infiltratingdendritic cell density and 5-year survival from human breast cancer. Br. J. Cancer 89, 533-538.
<https://doi.org/10.1038/sj.bjc.6601114>
5. , R. M., Christakos, P., Lee, K., Egawa, S., Son, Y.-I., Lotze, M. T. (2002) Paucity of dendritic cells in pancreatic cancer. Surgery 131, 135-138.
<https://doi.org/10.1067/msy.2002.119937>
6. , J., Chen, D., Kashiwaba, M., Kufe, D. (1997) Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells. Nat. Med. 3, 558-561.
<https://doi.org/10.1038/nm0597-558>
7. , S., Natsugoe, S., Tokuda, K., Nakajo, A., Xiangming, C., Iwashige, H., Aridome, K., Hokita, S., Aikou, T. (2000) Clinical impact of intratumoral natural killer cell and dendritic cell infiltration in gastric cancer. Cancer Lett. 159, 103-108.
<https://doi.org/10.1016/S0304-3835(00)00542-5>
8. , T., Akasaki, Y., Irie, I., Homma, S., Abe, T., Ohno, T. (2001) Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells. Cancer Immunol. Immunother. 50, 337-344.
<https://doi.org/10.1007/s002620100205>
9. , A., Stuhler, G., Walden, P., Zoller, P., Zobywalski, A., Brossart, P., Trefzer, U., Ullrich, S., Müller, C. A., Becker, V., Gross, A. J., Hemmerlein, B., Kanz, L., Müller, G. A., Ringert, R.-H. (2000) Regression of human metastatic renal cell carcinoma atter vaccination with tumor cell-dendritic cell hybrids. Nat. Med. 6, 332-336.
<https://doi.org/10.1038/73193>
10. , K. Y., Guarnieri, F. G., Staveley, O. K., Levitsky, H. I., August, J. T., Pardoll, D. M., Wu, T. C. (1996) Treatment of established tumours with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res. 56, 21-26.
11. , L., Bubeník, J., Šímová, J., Korb, J., Bieblová, J., Vonka, V., Indrová, M., Mikyšková, R., Jandlová, T. (2002) Tumour-inhibitory effects of dendritic cells administered at the site of HPV 16-induced neoplasms. Folia Biol. (Praha) 48, 114-119.
12. , L., Bubeník, J., Šímová, J., Jandlová, T., Vonka, V., Mikyšková, R. (2003) Prophylactic, therapeutic and antimetastatic effects of BMDC and DC lines in mice carrying HPV 16-associated tumours. Int. J. Oncol. 23, 243-247.
13. , R. J., Schauer, D., Bin, Q., Johnson, B. D. (2001) Electrofusion of a weakly immunogenic neuroblastoma with dendritic cells produces a tumour vaccine. Cell. Immunol. 213, 4-13.
<https://doi.org/10.1006/cimm.2001.1864>
14. , G., Märted, A., Kiske, S. M. Feil, F., Schmidt-Wolf, I. G. H. (2002) Generation of dendritic cell-based vaccines for cancer therapy. Br. J. Cancer 86, 1529-1533.
<https://doi.org/10.1038/sj.bjc.6600316>
15. , Z., Reznikoff, G., Dranoff, G., Rock, K. L. (1997) Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J. Immunol. 158, 2723-2730.
<https://doi.org/10.4049/jimmunol.158.6.2723>
16. , R. M. (1991) The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9, 271-276.
<https://doi.org/10.1146/annurev.iy.09.040191.001415>
17. , S., Kakeji, Y., Watanabe, A., Kohnoe, S., Maehara, Y., Sugimaghi, K. (1992) Infiltration of S-100 protein positive dendritic cells and peritoneal recurrence in advanced gastric cancer. Int. Surg. 77, 238-241.
18. , U., Weingart, G., Chen, Y., Herberth, G., Adrian, K., Winter, H., Audring, H., Guo, Z., Sterry, W., Walden, P. (2000) Hybrid cell vaccination for cancer immune therapy: first clinical trial with metastatic melanoma. Int. J. Cancer 85, 618-626.
<https://doi.org/10.1002/(SICI)1097-0215(20000301)85:5<618::AID-IJC4>3.0.CO;2-Z>
19. , J., Saffold, S., Cao, X., Krauss, J., Chen W. (1998) Eliciting T cell immunity against poorly immunogenic tumours by immunization with dendritic cell-tumor fusion vaccines. J. Immunol. 161, 5516-5526.
<https://doi.org/10.4049/jimmunol.161.10.5516>
